Kreos Capital

Kreos Capital is a leading provider of growth debt to high-growth companies in Europe, focusing on firms with revenues up to €150 million. Established in 1998, it operates primarily in Western Europe, the Nordics, and Israel, having completed nearly 450 transactions and committed €1.8 billion across 14 countries. The firm specializes in offering flexible financing solutions, including growth capital and acquisition financing, particularly in the technology and healthcare sectors. Kreos Capital works closely with company management teams and their equity sponsors, providing necessary capital while minimizing equity dilution. Its experienced team, based in London, Tel Aviv, and Stockholm, has a strong background in debt financing and equity investing, enabling them to support companies throughout their growth cycles effectively.

Aris Constantinides

General Partner

Tim Fenwick

Principal

Uri Galai

Partner

Parag Gandesha

General Partner and COO

124 past transactions

Sequana Medical

Post in 2022
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.

Treasury Intelligence Solutions

Debt Financing in 2022
Treasury Intelligence Solutions GmbH, founded in 2010 and based in Walldorf, Germany, offers a robust Software-as-a-Service platform designed for medium and large enterprises to manage corporate payments, liquidity, and bank relationships globally. The company provides several key products, including the Bank Transaction Manager, a web-based, multi-bank payment platform that ensures efficient, transparent, and secure payment processes with features like audit-proof tracking, workflow-based approvals, and automatic bank statement retrieval. Additionally, the Bank Account Manager serves as a centralized tool for managing and monitoring bank accounts, while the Bank Fee Manager allows businesses to oversee and analyze bank charges and relationships. TIS aims to enhance cash flow visibility and decision-making for its customers while delivering significant cost savings and risk management benefits. The company has established strategic alliances, including one with Cashforce, and has earned recognition as one of Europe’s fastest-growing companies, with a strong customer base that includes numerous DAX-listed firms. The platform's high security and integration capabilities are certified by various international standards.

Pyramid Analytics

Series E in 2022
Pyramid Analytics BV specializes in developing business intelligence and data analytics solutions, headquartered in Amsterdam, Netherlands, with additional locations in the United States, the United Kingdom, and Israel. Established in 2009, the company offers an adaptive analytic platform called Analytics OS that caters to various user needs and skills while allowing content to be managed as a shared resource. Their solutions include self-service analytics for business users, analysts, and IT professionals, as well as operational analytics aimed at enhancing analytics strategy and infrastructure. The platform is designed to simplify access to information, enabling organizations across sectors such as education, retail, manufacturing, government, financial services, insurance, and healthcare to optimize their operations through an integrated and scalable dashboard.

PolyPid

Post in 2022
PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID–500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.

VectivBio

Post in 2022
VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing rare diseases with well-defined biology that can be targeted with best-in-disease therapies that have the potential to meaningfully transform and improve the lives of patients and their families, not just provide an incremental improvement or benefit over the standard-of-care. It was founded as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia. VectivBio was incorporated in 2019 and is based in Basel, Switzerland.

Moove

Series A in 2022
Operator of a global mobility fintech company intended to democratize access to financial services for mobility entrepreneurs. The company uses embedded alternative credit scoring technology in ride-hailing, logistics, mass transit, and instant delivery platforms, using proprietary performance and revenue analytics to underwrite customers that have previously been excluded from financial services, enabling customers to access and use proprietary performance and revenue analytics of mobility entrepreneurs to underwrite loans.

Scandit

Series D in 2022
Scandit AG, established in 2009 and headquartered in Zurich, Switzerland, specializes in mobile computer vision and augmented reality solutions, focusing on barcode scanning software. Its offerings include the Scandit Keyboard Wedge, which enables enterprise-grade barcode scanning on mobile devices, and the Barcode Scanner SDK, which allows for barcode scanning integration in web applications. The MatrixScan technology enhances the speed of barcode and text recognition, making it valuable for industries such as retail, logistics, manufacturing, healthcare, and government. Scandit's solutions are designed to improve operational efficiency by enabling mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating patient and medication tracking in healthcare settings. The company serves a diverse clientele, including well-known organizations like 7-Eleven, Carrefour, and Toyota, among others, and has additional offices in San Francisco, Boston, London, and Warsaw.

Numan

Debt Financing in 2022
Numan is a startup focused on addressing erectile dysfunction and other health issues, including weight loss, through an online clinic model. The company provides accessible medical solutions by combining prescription medications, doctor consultations, and diagnostic services. Numan's platform emphasizes the importance of tackling health concerns that impact men's self-esteem and lifestyle choices. By offering direct-to-consumer medical products, Numan enables individuals to manage their symptoms and explore alternative treatments conveniently online.

Numa

Venture Round in 2022
Numa, operating under the brand COSI Hospitality GmbH, specializes in designing, developing, and managing lifestyle apartments tailored for weekend getaways, business trips, and temporary living arrangements. Based in Berlin, Germany, the company focuses on providing uniquely designed accommodations that cater to the needs of modern travelers. In addition to its hospitality services, Numa builds a technology and data platform that aims to enhance the integration of hospitality services, real estate, and guest experiences, thereby creating a seamless and innovative experience for users.

FintechOS

Series B in 2022
FintechOS SRL is a Romanian company that develops an artificial intelligence-enabled platform tailored for financial institutions, focusing on digital transformation. Founded in 2017 and headquartered in Bucharest, the company offers a comprehensive open-cloud, omni-channel orchestration platform that includes applications such as Digital Experience Portal, Digital Customer 360, and Digital Product Factory. These tools are designed to enhance customer experiences for banking and insurance firms. Additionally, FintechOS provides the FintechOS Academy, which offers e-learning solutions to support ongoing education and skills development. By leveraging advanced technologies and a hybrid agile methodology, FintechOS enables rapid and cost-effective digital transformation for its clients, facilitating the delivery of personalized services that meet modern consumer demands.

Voi

Series D in 2021
Voi Technology is a provider of mobility services specializing in electric scooters for urban commuters. Founded in 2018 and headquartered in Stockholm, Sweden, the company aims to create a network of electric scooters to offer an affordable and sustainable commuting option. Voi's services are accessible through a mobile application, enabling users to rent scooters conveniently with options for day passes or monthly subscriptions. By promoting the use of electric vehicles, Voi seeks to help individuals reduce their carbon footprint and contribute to more sustainable urban transportation systems.

Biophytis

Post in 2021
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options. To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.

Recharge

Series B in 2021
Recharge, based in Amsterdam, Netherlands, specializes in simplifying the process of prepaid credit and top-up services. The company aims to disrupt the traditional, often slow market by providing a fast, safe, and convenient online recharge experience for customers worldwide. With a focus on accessibility, Recharge seeks to offer its services anytime and anywhere, catering to a diverse range of users. The company is dedicated to expanding its presence in the online recharge sector and is actively seeking talented professionals to support its growth and innovation in this rapidly evolving industry.

EGYM

Series E in 2021
EGYM specializes in enhancing the gym experience for operators, trainers, and members through innovative technology solutions. The company provides a cloud platform that connects various training hardware, allowing for seamless data access via its Trainer and Member Apps. EGYM has also developed smart strength machines that integrate with this cloud system, promoting a more efficient workout environment. By offering a B2B corporate fitness subscription solution, EGYM caters to employers and delivers personalized, data-driven fitness experiences for employees and gym users. This approach enables fitness enthusiasts to achieve their training goals, including muscle gain, performance improvement, and rehabilitation.

Refurbed

Series B in 2021
Refurbed GmbH is an online marketplace based in Vienna, Austria, specializing in the sale of refurbished electronic goods. Founded in 2017, the company focuses on offering a wide range of products, including smartphones, laptops, tablets, televisions, and kitchen appliances, all at prices up to 40% lower than new items. Refurbed's products undergo a comprehensive 40-step refurbishment process, ensuring they look and function like new. Each device comes with a minimum 12-month guarantee, highlighting the company's commitment to quality and customer satisfaction. By promoting the purchase of refurbished products, Refurbed not only helps consumers save money but also supports environmentally sustainable practices in the electronics market.

Refurbed

Series B in 2021
Refurbed GmbH is an online marketplace based in Vienna, Austria, specializing in the sale of refurbished electronic goods. Founded in 2017, the company focuses on offering a wide range of products, including smartphones, laptops, tablets, televisions, and kitchen appliances, all at prices up to 40% lower than new items. Refurbed's products undergo a comprehensive 40-step refurbishment process, ensuring they look and function like new. Each device comes with a minimum 12-month guarantee, highlighting the company's commitment to quality and customer satisfaction. By promoting the purchase of refurbished products, Refurbed not only helps consumers save money but also supports environmentally sustainable practices in the electronics market.

Expertlead

Series B in 2021
Expertlead is a global community of highly qualified tech freelancers, dedicated to enhancing the self-employment journey for its members. Potential members are rigorously evaluated through coding tests and technical interviews to ensure high standards within the exclusive network. Expertlead assists freelancers at various stages of their careers, offering support in project acquisition, relevant services, further training, peer-to-peer learning, and administrative tasks. For companies, Expertlead provides a platform that facilitates the technical assessment of technology specialists, granting access to a curated talent pool for project-based collaborations. By leveraging technology, Expertlead effectively matches client needs with quality-tested freelancers, enabling efficient recruitment for complex digital implementation projects.

Motus GI

Post in 2021
Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.

Calliditas Therapeutics

Debt Financing in 2021
Calliditas Therapeutics, a specialty pharmaceutical company that develops pharmaceutical products in fields of unmet medical need. Its products include Nefecon, a treatment for IgA nephropathy and Busulipo, an alternative for myeloablation prior to bone marrow transplantation. The company was founded in 1991 and is headquartered in Stockholm, Sweden.

Grover

Debt Financing in 2021
Grover Group GmbH is a Berlin-based company that operates an online platform allowing customers to rent consumer electronic products through a monthly subscription model. Founded in 2015, Grover offers a diverse range of over 1,500 products across various categories, including smartphones, laptops, wearables, cameras, gaming equipment, home entertainment systems, and smart home devices. This approach enables both private customers and businesses to access the latest technology without the financial burden of ownership, promoting flexibility and convenience in the consumer electronics market. With additional offices in Austria and the Netherlands, Grover is committed to enhancing the access economy by providing a simple and efficient rental service.

Recharge

Debt Financing in 2021
Recharge, based in Amsterdam, Netherlands, specializes in simplifying the process of prepaid credit and top-up services. The company aims to disrupt the traditional, often slow market by providing a fast, safe, and convenient online recharge experience for customers worldwide. With a focus on accessibility, Recharge seeks to offer its services anytime and anywhere, catering to a diverse range of users. The company is dedicated to expanding its presence in the online recharge sector and is actively seeking talented professionals to support its growth and innovation in this rapidly evolving industry.

PlusDental

Venture Round in 2021
PlusDental, founded in 2017 and based in Berlin, Germany, specializes in digital orthodontics, focusing on cosmetic cases of malocclusion through the use of clear aligners. The company aims to revolutionize aesthetic orthodontics in Europe by leveraging innovative technology to provide treatments that are convenient and affordable. PlusDental operates in a rapidly expanding market for clear aligners, seeking to enhance accessibility for customers who can benefit from this effective and versatile treatment method. With a team composed of both business professionals and dental experts, PlusDental is committed to improving the orthodontic treatment experience.

TME Pharma

Post in 2021
TME Pharma is a biotechnology company based in Berlin, Germany, focused on developing innovative therapeutics for cancer treatment. The company utilizes its proprietary Spiegelmer platform, which involves biostable aptamers and mirror image nucleic acids, to create a pipeline of clinical-stage product candidates. Its lead drug candidate, NOX-A12, is being investigated as a combination therapy for various cancer types, including metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia. TME Pharma is also advancing NOX-E36, which has completed Phase IIa trials for diabetic nephropathy. The company has established partnerships, including a collaboration with Merck & Co. to explore the efficacy of NOX-A12 in combination with Keytruda in patients with metastatic solid tumors. Founded in 1997, TME Pharma continues to advance its mission of developing novel treatments for serious medical conditions.

Numa

Series A in 2021
Numa, operating under the brand COSI Hospitality GmbH, specializes in designing, developing, and managing lifestyle apartments tailored for weekend getaways, business trips, and temporary living arrangements. Based in Berlin, Germany, the company focuses on providing uniquely designed accommodations that cater to the needs of modern travelers. In addition to its hospitality services, Numa builds a technology and data platform that aims to enhance the integration of hospitality services, real estate, and guest experiences, thereby creating a seamless and innovative experience for users.

Branded

Venture Round in 2021
Branded acquires and partners with top performing Amazon sellers & Brands

Quali

Series D in 2021
QualiSystems Ltd. develops and markets software test automation solutions for telecom equipment, network services and embedded system testing. Its TestShell software framework optimize device and systems testing while reducing testing time and overhead efforts. The framework covers the entire testing cycle with GUI based test editor, automated parallel test execution, vendor agnostic integration to existing test equipment, automated topology set up, resources scheduling, lab management and reporting and analysis capabilities. The company headquarters and expert R&D team are located in Israel. Direct Sales and Customer Support centers are held in United States, United Kingdom, Singapore, China, Germany, Korea and Taiwan. Partner representatives are held across EMEA, APAC and North America. The company was founded in 2004 as Nibea Quality Management Solutions and changed its name to QualiSystems Ltd. in March 2007.

Kandou

Series C in 2020
Kandou Bus SA is a company that specializes in designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Switzerland, Kandou has developed a unique approach to serial link design that enhances data transfer speeds while minimizing power consumption. Their technology is utilized across various electronic devices, including DRAM, graphics cards, server backplanes, mobile devices, and game consoles, effectively increasing data throughput and extending battery life. Additionally, Kandou's solutions address the growing demand for bandwidth in applications such as routers and FPGAs, where they improve performance while reducing pin counts and overall energy usage. The company operates with a team of skilled scientists and engineers across Switzerland, the UK, and the US, focusing on advancing the capabilities of serial links to support innovative electronic designs.

Syte

Series C in 2020
Syte develops a product discovery platform designed to transform the way people search and shop online. It is a provider of visual AI technology that aims to improve retailers’ site navigation, product discovery, and user experience by powering solutions that engage and convert shoppers. The B2B enterprise's solution includes camera search, augmented site search, personalization engines, and smart in-store tools, empower shoppers to discover and purchase products instantly. Their camera solution enables shoppers to take a picture of a product that inspires them and search for visually similar products within a retailer’s site. Up to date, Syte has raised $71 million from investors including Viola Ventures, LG Tech Ventures, NHN Ventures, Kreos Capital, Naver Corporation, Commerce Ventures, Storm Ventures, Axess Ventures, La Maison, MizMaa Ventures, Magma, Naver Corporation, Line Corporation, Reimage Ventures, North Base Media, and KDC Ventures. In 2014, Helge Voss, Idan Pinto, Lihi Pinto Fryman, and Ofer Fryman established Syte in Tel Aviv, Tel Aviv.

Neuromod

Series B in 2020
Neuromod Devices Limited is a medical device company based in Dublin, Ireland, established in 2010. It focuses on the research and development of neuromodulation treatments, specifically targeting chronic tinnitus, a condition that affects approximately 10% of adults. The company's flagship product, the mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the nervous system. Neuromod aims to provide effective treatments for underserved patient populations suffering from chronic and debilitating conditions, enabling them to manage their health more effectively. The company has developed and patented its bi-modal neuromodulation technology, which is also being explored for other neurological disorders.

Abivax

Post in 2020
Abivax is a clinical-stage biotechnology company based in Paris, France, dedicated to discovering and optimizing treatments for inflammatory diseases, viral infections, and cancer. The company is primarily focused on its lead product, ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis and Crohn’s Disease, as well as for COVID-19. Additionally, ABX464 is being evaluated in Phase IIa trials for rheumatoid arthritis and has completed Phase IIa trials aimed at achieving viral remission in HIV patients. Abivax is also developing ABX 196, an immune enhancer in Phase 1/2 trials for hepatocellular cancer, and ABX 544, a candidate for Ebola treatment based on polyclonal antibodies. Furthermore, the company is conducting research into treatments for Dengue fever, influenza, and respiratory syncytial virus. Abivax collaborates with institutions such as the French National Centre for Scientific Research and the University of Montpellier. Founded in 2013, the company aims to harness the body’s immune response to manage chronic inflammatory conditions effectively.

Bnext

Series A in 2020
Bnext is a fintech platform based in Madrid, Spain, that offers a comprehensive alternative to traditional banking services. It allows users to create current accounts quickly and access various financial products through its innovative Marketplace, which features carefully selected offerings from fintechs and banks. Users can connect their external accounts to manage all their financial information in one place, facilitating easier financial oversight. Bnext's model emphasizes collaboration with financial service providers rather than imposing high commissions on customers, ensuring users receive competitive offers. The platform provides a wide range of services, including real estate investment, mutual funds, loans, crowdfunding, and more. By integrating leading products in the market, Bnext aims to redefine banking and position itself as a modern alternative to conventional banks.

Voi

Series B in 2020
Voi Technology is a provider of mobility services specializing in electric scooters for urban commuters. Founded in 2018 and headquartered in Stockholm, Sweden, the company aims to create a network of electric scooters to offer an affordable and sustainable commuting option. Voi's services are accessible through a mobile application, enabling users to rent scooters conveniently with options for day passes or monthly subscriptions. By promoting the use of electric vehicles, Voi seeks to help individuals reduce their carbon footprint and contribute to more sustainable urban transportation systems.

ViCentra

Venture Round in 2020
ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Zerto

Debt Financing in 2020
Zerto Ltd. specializes in disaster recovery and business continuity software tailored for virtualized data centers and cloud environments. The company's core offering, the Zerto Cloud Continuity Platform, includes Zerto Virtual Replication, which facilitates the protection, recovery, and migration of applications across various cloud settings, including public, private, and hybrid clouds. Zerto's products support critical applications such as Oracle, SAP, and SQL Server, ensuring uninterrupted operations for clients across diverse sectors, including healthcare, legal, and finance. Founded in 2009 and headquartered in Herzliya, Israel, Zerto also maintains offices in key locations worldwide, including Boston, Shinjuku, Reading, Mumbai, and several areas in Canada and Latin America.

Smava

Debt Financing in 2020
Smava GmbH operates an online loan comparison portal based in Berlin, Germany, founded in 2005. The platform connects private borrowers with a diverse range of banks and private investors, offering personal loans, car loans, debt restructuring options, and credit cards. Smava facilitates a tailored loan experience, enabling customers to secure loans quickly with varying amounts and interest rates. The company has seen significant growth, with the volume of loans brokered increasing from approximately EUR 2 billion in 2018 to around EUR 2.7 billion in 2019, and further rising by 45% in the first quarter of 2020 compared to the same period the previous year. To date, Smava has brokered over 8 billion euros in loans, establishing itself as a prominent player in the German credit market.

Scandit

Series C in 2020
Scandit AG, established in 2009 and headquartered in Zurich, Switzerland, specializes in mobile computer vision and augmented reality solutions, focusing on barcode scanning software. Its offerings include the Scandit Keyboard Wedge, which enables enterprise-grade barcode scanning on mobile devices, and the Barcode Scanner SDK, which allows for barcode scanning integration in web applications. The MatrixScan technology enhances the speed of barcode and text recognition, making it valuable for industries such as retail, logistics, manufacturing, healthcare, and government. Scandit's solutions are designed to improve operational efficiency by enabling mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating patient and medication tracking in healthcare settings. The company serves a diverse clientele, including well-known organizations like 7-Eleven, Carrefour, and Toyota, among others, and has additional offices in San Francisco, Boston, London, and Warsaw.

Inotrem

Debt Financing in 2020
Inotrem S.A. is a biotechnology company based in Paris, France, specializing in the discovery and development of innovative treatments for inflammatory pathologies, particularly in critical care settings. Founded in 2013, the company focuses on immunotherapy and has created a novel immunomodulation approach targeting the TREM-1 pathway to manage excessive inflammation. Its lead product, nangibotide (also known as LR12), is a first-in-class TREM-1 inhibitor designed to address severe conditions such as septic shock and myocardial infarction. Inotrem is also advancing a program aimed at treating chronic inflammatory diseases, leveraging its proprietary technology platform to develop new therapeutic modalities.

Funnel

Series B in 2020
Funnel Operation AB, founded in 2014 and headquartered in Stockholm, Sweden, specializes in marketing analytics and reporting software designed to automate data collection for marketers. The company's platform integrates with over 400 marketing and advertising sources, allowing users to streamline data feeding into various tools such as Business Intelligence systems, Data Warehouses, Google Sheets, Google Data Studio, and Google Analytics. Funnel's offerings include dashboards and reports for simplified marketing analysis, a data studio connector for aggregating marketing data, and APIs that facilitate data collection and distribution. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B companies, mobile applications, and gaming firms, helping them manage advertising performance data effectively and gain insights for informed decision-making.

GenSight Biologics

Post in 2019
GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, specializing in the discovery and development of gene therapy treatments for retinal degenerative diseases and neurodegenerative disorders of the central nervous system. The company utilizes two primary technology platforms: mitochondrial targeting sequences and optogenetics, aiming to preserve or restore vision in patients affected by severe retinal diseases. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III clinical trials for treating Leber hereditary optic neuropathy associated with ND4 gene mutations, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. Additionally, GenSight is advancing various preclinical programs targeting both ophthalmic and neurodegenerative conditions, reflecting its commitment to innovative solutions for patients with significant vision impairment or blindness. GenSight Biologics was founded in 2012.

Voi

Series B in 2019
Voi Technology is a provider of mobility services specializing in electric scooters for urban commuters. Founded in 2018 and headquartered in Stockholm, Sweden, the company aims to create a network of electric scooters to offer an affordable and sustainable commuting option. Voi's services are accessible through a mobile application, enabling users to rent scooters conveniently with options for day passes or monthly subscriptions. By promoting the use of electric vehicles, Voi seeks to help individuals reduce their carbon footprint and contribute to more sustainable urban transportation systems.

Typelane

Seed Round in 2019
Typelane is a company dedicated to enhancing employee onboarding and offboarding processes. By prioritizing smart workflows, intuitive design, and personalization, Typelane simplifies what has traditionally been a manual and complex experience. The platform aims to make the transition of welcoming new employees and saying farewell to departing ones more efficient and engaging, thereby transforming these critical phases of the employment lifecycle into seamless experiences for both employers and employees.

MDxHealth

Post in 2019
MDxHealth is a molecular diagnostics company focused on developing and commercializing advanced tests to assist in cancer detection and treatment. The company offers a range of products, including ConfirmMDx, a prostate cancer tissue test aimed at addressing false-negative biopsy results; SelectMDx, a non-invasive urine test for prostate cancer; and AssureMDx, a liquid biopsy test for bladder cancer that aids in cystoscopy decisions. Additionally, MDxHealth provides PredictMDx, a tissue methylation test designed to inform treatment decisions for glioblastoma. Founded in 2003 and headquartered in Herstal, Belgium, with offices in Irvine, California, and Nijmegen, the Netherlands, MDxHealth operates internationally, serving markets across Europe and the United States. The company specializes in epigenetic and molecular technologies to enhance the accuracy of cancer diagnoses and tailor personalized treatment strategies for patients.

Neuromod

Series A in 2019
Neuromod Devices Limited is a medical device company based in Dublin, Ireland, established in 2010. It focuses on the research and development of neuromodulation treatments, specifically targeting chronic tinnitus, a condition that affects approximately 10% of adults. The company's flagship product, the mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the nervous system. Neuromod aims to provide effective treatments for underserved patient populations suffering from chronic and debilitating conditions, enabling them to manage their health more effectively. The company has developed and patented its bi-modal neuromodulation technology, which is also being explored for other neurological disorders.

Kandou

Series C in 2019
Kandou Bus SA is a company that specializes in designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Switzerland, Kandou has developed a unique approach to serial link design that enhances data transfer speeds while minimizing power consumption. Their technology is utilized across various electronic devices, including DRAM, graphics cards, server backplanes, mobile devices, and game consoles, effectively increasing data throughput and extending battery life. Additionally, Kandou's solutions address the growing demand for bandwidth in applications such as routers and FPGAs, where they improve performance while reducing pin counts and overall energy usage. The company operates with a team of skilled scientists and engineers across Switzerland, the UK, and the US, focusing on advancing the capabilities of serial links to support innovative electronic designs.

BUX

Venture Round in 2019
BUX is a financial technology company based in Amsterdam, founded in 2014, that provides mobile platforms for commission-free stock investing and CFD trading. The company's applications are designed to lower the barriers to financial markets, allowing users to buy shares and invest in real cryptocurrencies without incurring fees. BUX aims to offer a seamless and user-friendly experience, catering to both seasoned investors and those new to the stock market. By focusing on accessibility and affordability, BUX enables individuals to engage in financial markets more easily.

Gett

Series E in 2019
Gett, Inc. is a technology company that specializes in providing on-demand black car services through a SaaS-based platform tailored for corporate transportation. Founded in 2006 and headquartered in New York, with additional offices in London, Moscow, and Tel Aviv, Gett facilitates taxi bookings via its mobile application across several countries, including the United States, the United Kingdom, and Israel. The platform integrates various ride-hailing options, allowing businesses to optimize their ground travel experience, which includes features such as automatic invoicing and analytics. Gett aims to streamline corporate travel and has demonstrated its effectiveness by helping clients reduce their global ground travel costs by approximately 25%. The company has established a strategic partnership with Volkswagen Group and serves a diverse clientele, including a significant number of Fortune 500 companies.

Butternut Box

Series B in 2019
Butternut Box is a direct-to-consumer pet wellness company that specializes in freshly prepared dog food designed to enhance the health of dogs. The meals are cooked in a manner similar to home cooking and are delivered in precise portions tailored to each individual dog based on factors such as breed, gender, age, and weight. Butternut Box is committed to providing dogs with the healthiest, most natural food, free from artificial ingredients. This approach allows pet owners to ensure their dogs receive nutritious meals that meet their specific dietary needs, contributing to improved overall health and well-being.

SuperSonic Imagine

Post in 2018
SuperSonic Imagine SA operates as a medical technology company. It designs, develops, and markets Aixplorer, an ultrasound system. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company’s products include Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution. It operates primarily in China, the United States, and France. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.

Quali

Series C in 2018
QualiSystems Ltd. develops and markets software test automation solutions for telecom equipment, network services and embedded system testing. Its TestShell software framework optimize device and systems testing while reducing testing time and overhead efforts. The framework covers the entire testing cycle with GUI based test editor, automated parallel test execution, vendor agnostic integration to existing test equipment, automated topology set up, resources scheduling, lab management and reporting and analysis capabilities. The company headquarters and expert R&D team are located in Israel. Direct Sales and Customer Support centers are held in United States, United Kingdom, Singapore, China, Germany, Korea and Taiwan. Partner representatives are held across EMEA, APAC and North America. The company was founded in 2004 as Nibea Quality Management Solutions and changed its name to QualiSystems Ltd. in March 2007.

Affluent Medical

Debt Financing in 2018
Affluent Medical is a medical device company based in Paris, France, specializing in the design, development, manufacturing, and marketing of implantable prostheses. Founded in 2011, the company focuses on next-generation minimally invasive devices aimed at treating severe medical conditions. Its product lineup includes the Kardiozis prosthesis, which addresses abdominal aortic aneurysms, and the Kalios and Epygon implants, designed for mitral valve repair and replacement. Kalios addresses post-operative leakage and recurrent mitral insufficiency without the need for additional surgeries, while Epygon is notable for being a developing transcatheter valve that restores natural blood flow. Additionally, Affluent Medical has created Artus, the first electronically activatable artificial sphincter for the treatment of severe urinary incontinence in both men and women.

Planday

Series C in 2018
Planday bring down staff costs by 5%, reduce administration time by 75% and increase employee satisfaction by 20%. Planday is used by different sized companies in a variety of industries such as Restaurants, Hotels, Retailers, Call Centres, Fitness clubs, etc. Want to know more about Planday? Visit planday.com today.

Kiadis Pharma

Post in 2018
Kiadis Pharma N.V. is a biopharmaceutical company based in Amsterdam, specializing in cell-based immunotherapy products for blood cancer treatment. The company is developing K-NK002, currently in Phase II clinical trials, as an adjunctive immunotherapeutic for blood cancer patients undergoing haploidentical hematopoietic stem cell transplantation with the post-transplant cyclophosphamide protocol. K-NK003 is another product in Phase I/II trials, targeting patients with acute myeloid leukemia relapse or refractory cases. Additionally, Kiadis Pharma is working on K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company has established collaborations for the development of a combination therapy involving monoclonal antibodies and natural killer cells to address COVID-19. Kiadis Pharma focuses on addressing the complications and limitations associated with hematopoietic stem cell transplants, offering novel treatment options for terminally ill cancer patients with significant unmet medical needs.

Abivax

Post in 2018
Abivax is a clinical-stage biotechnology company based in Paris, France, dedicated to discovering and optimizing treatments for inflammatory diseases, viral infections, and cancer. The company is primarily focused on its lead product, ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis and Crohn’s Disease, as well as for COVID-19. Additionally, ABX464 is being evaluated in Phase IIa trials for rheumatoid arthritis and has completed Phase IIa trials aimed at achieving viral remission in HIV patients. Abivax is also developing ABX 196, an immune enhancer in Phase 1/2 trials for hepatocellular cancer, and ABX 544, a candidate for Ebola treatment based on polyclonal antibodies. Furthermore, the company is conducting research into treatments for Dengue fever, influenza, and respiratory syncytial virus. Abivax collaborates with institutions such as the French National Centre for Scientific Research and the University of Montpellier. Founded in 2013, the company aims to harness the body’s immune response to manage chronic inflammatory conditions effectively.

Signal AI

Series B in 2018
Signal AI is an artificial intelligence media monitoring company that specializes in providing real-time information and insights for media monitoring, reputation management, and market intelligence. Founded in 2013 and headquartered in London, the company aggregates and analyzes data from various sources, including digital, print, and broadcast media, as well as regulatory materials. Signal AI employs machine learning to deliver comprehensive news coverage and insights, helping business leaders track their competitive landscape and monitor changes in regulation. This technology empowers organizations to make informed decisions quickly, enhancing their ability to manage their reputation and respond effectively to emerging trends and events. In addition to its London headquarters, Signal AI has offices in New York and Hong Kong.

BioCatch

Series B in 2018
BioCatch is a Boston-based company that specializes in behavioral authentication and threat detection solutions for web and mobile applications. Founded in 2011, it utilizes advanced cognitive science and machine learning to analyze over 2,000 cognitive parameters, creating unique user profiles. The platform is designed to continuously authenticate users throughout their online sessions, effectively safeguarding against cyber threats and fraudulent activities such as account takeovers and automated account manipulation. BioCatch's behavioral biometrics technology identifies potentially risky digital behaviors and sophisticated social engineering scams, helping organizations, particularly banks, enhance fraud detection while minimizing friction during the digital user journey. This approach enables a secure and seamless experience for users, reinforcing identity and trust without compromising privacy.

Profile Pensions

Debt Financing in 2018
Profile Pensions is a UK-based provider of pension advisory services aimed at helping individuals understand and improve their retirement savings. The company offers impartial and expert advice, making pension investment guidance accessible to a wide range of clients, regardless of their financial knowledge or status. Their services include recommending investment funds, tracing lost pensions, and providing a pension calculator, all designed to empower clients to enhance their pension wealth. By focusing on affordability and accessibility, Profile Pensions aims to assist individuals in taking proactive steps toward securing a better financial future in retirement.

Currencycloud

Debt Financing in 2018
Currencycloud is a global payments platform that simplifies the process of moving money across borders. It offers businesses an API-based infrastructure that allows developers to create customized payment solutions tailored to their specific needs. The platform facilitates seamless transactions in multiple currencies, providing automated end-to-end payment processes, collection and conversion services, and digital currency management. By handling the complexities and regulatory requirements of cross-border payments, Currencycloud enables clients to integrate financial services into their operations, empowering them to operate more effectively in the digital economy.

Mereo Biopharma

Post in 2017
Mereo is based in London and was founded in March 2015 to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies. Pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs. With significant P&L constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates, especially beyond Phase 2. Mereo has been formed to take advantage of the global pharmaceutical industry's drive for creative ways to progress their clinical development pipelines. Mereo has acquired an initial mid-late stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from Novartis Pharmaceuticals. Each of these programmes has a comprehensive dataset for both pre-clinical and proof-of-concept clinical studies. Additional product opportunities are under evaluation. Mereo's focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world. To do this, the Company depends on the combination of its team's expertise in selecting and acquiring product opportunities, creating value in the development pipeline and structuring creative transactions. Mereo's internal expertise is complemented by a unique partnership with a leading global CRO, ICON. Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products. The Company also has the option to directly commercialise products, for example in orphan disease indications.

Kiadis Pharma

Post in 2017
Kiadis Pharma N.V. is a biopharmaceutical company based in Amsterdam, specializing in cell-based immunotherapy products for blood cancer treatment. The company is developing K-NK002, currently in Phase II clinical trials, as an adjunctive immunotherapeutic for blood cancer patients undergoing haploidentical hematopoietic stem cell transplantation with the post-transplant cyclophosphamide protocol. K-NK003 is another product in Phase I/II trials, targeting patients with acute myeloid leukemia relapse or refractory cases. Additionally, Kiadis Pharma is working on K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company has established collaborations for the development of a combination therapy involving monoclonal antibodies and natural killer cells to address COVID-19. Kiadis Pharma focuses on addressing the complications and limitations associated with hematopoietic stem cell transplants, offering novel treatment options for terminally ill cancer patients with significant unmet medical needs.

Puls

Series B in 2017
Puls is a venture-funded startup based in San Francisco, California, that operates a nationwide platform connecting customers with service providers for a range of home services. Founded in 2015, the company specializes in handyman services, appliance repair, TV mounting, and disinfection. Its offerings include furniture assembly, wall hanging, drywall repair, interior painting, and installation of various appliances and devices. Additionally, Puls provides same-day repair services for tech devices, Wi-Fi configuration, garage door installation, and security system setup. By facilitating convenient access to local technicians, Puls aims to meet the diverse needs of homeowners and enhance their service experience.

Signal AI

Debt Financing in 2017
Signal AI is an artificial intelligence media monitoring company that specializes in providing real-time information and insights for media monitoring, reputation management, and market intelligence. Founded in 2013 and headquartered in London, the company aggregates and analyzes data from various sources, including digital, print, and broadcast media, as well as regulatory materials. Signal AI employs machine learning to deliver comprehensive news coverage and insights, helping business leaders track their competitive landscape and monitor changes in regulation. This technology empowers organizations to make informed decisions quickly, enhancing their ability to manage their reputation and respond effectively to emerging trends and events. In addition to its London headquarters, Signal AI has offices in New York and Hong Kong.

Cellnovo

Post in 2017
They believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition. The experience of managing diabetes should be as positive as possible. Thoughtful and innovative design should make things easier to understand and simpler to use. With belief in these ideals, they tore up convention. When they started, they did so with a focus only on how modern technology and beautiful design would make life easier for someone managing diabetes.

TME Pharma

Post in 2017
TME Pharma is a biotechnology company based in Berlin, Germany, focused on developing innovative therapeutics for cancer treatment. The company utilizes its proprietary Spiegelmer platform, which involves biostable aptamers and mirror image nucleic acids, to create a pipeline of clinical-stage product candidates. Its lead drug candidate, NOX-A12, is being investigated as a combination therapy for various cancer types, including metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia. TME Pharma is also advancing NOX-E36, which has completed Phase IIa trials for diabetic nephropathy. The company has established partnerships, including a collaboration with Merck & Co. to explore the efficacy of NOX-A12 in combination with Keytruda in patients with metastatic solid tumors. Founded in 1997, TME Pharma continues to advance its mission of developing novel treatments for serious medical conditions.

ROLI

Debt Financing in 2017
ROLI is creating the future of musical expression. It started with the Seaboard, an award-winning digital keyboard that you can play with all the depth and nuance of an acoustic instrument. ROLI now makes a huge range of music-making tools — from pocket-sized drum pads like the Lightpad Block to all-in-one systems like the Songmaker Kit. Its devices are incredibly expressive, and they’re also accessible. So whether creators are learning musical skills or honing their technique, they can make music in new ways with ROLI. ROLI investors include Sony Innovation Fund, Foundry Group, Firstmark Capital, Balderton Capital, Founders Forum, and Pharrell Williams (ROLI's Chief Creative Officer). Music creation hardware includes: Seaboard RISE 25, Seaboard RISE 49, Seaboard Block, Lightpad Block, Loop Block, Live Block, and Touch Block. Music creation software includes: Equator, Cypher2, Strobe2, and the NOISE for iOS app. Platform products include the C++ audio coding framework JUCE.

Proveca

Venture Round in 2017
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

SoundCloud

Debt Financing in 2017
SoundCloud is a social sound platform that enables users to create, upload, and share audio content, including music. Launched in 2008 by Alexander Ljung and Eric Wahlforss, it serves as a hub for a diverse community of creators and listeners. The platform allows sound creators to instantly record and distribute their works while providing them with detailed statistics and feedback from the community. SoundCloud connects artists with their fans globally, facilitating the promotion and sharing of music through blogs, websites, and social networks. This open platform not only helps artists distribute their work but also enhances the music discovery experience for users.

CrossLend

Debt Financing in 2017
CrossLend GmbH operates an online lending platform for digital credit mediation and financing. It provides cross-border credit mediation through cooperation with its partner bank. It also provides digital infrastructure, transformation, and standardisation. The company provides finance to marketplace, including consumer loan, development loan, invoices, mortgages, sme loans, and bridging loan. The company was founded in 2014 and is headquartered in Berlin, Germany.

Teridion

Venture Round in 2017
Teridion Technologies Ltd. offers a cloud-based wide area network (WAN) service that enhances connectivity and performance for enterprises and SaaS providers. Founded in 2013 and headquartered in Petah Tikva, Israel, Teridion operates through an extensive overlay network utilizing over 500 points of presence globally and partnerships with more than 25 public cloud providers. Its services include a cloud-native WAN that serves as a replacement for traditional multiprotocol label switching (MPLS), along with solutions for SaaS acceleration, cloud access, and site-to-site connectivity. By employing proprietary algorithms, Teridion optimizes traffic routing based on bandwidth, latency, and geography, enabling real-time management of internet congestion. This approach allows for significant improvements in throughput, achieving up to 20 times greater performance compared to standard public internet connections, making it an effective solution for global enterprises seeking to enhance their network capabilities.

Bonesupport

Venture Round in 2016
BONESUPPORT is a medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures. The company's mission is to restore health to enhance the quality of life for patients with bone disorders. BONESUPPORT was founded on 2000 and is headquartered in Lund, Sweden.
Electro Power Systems operates in the sustainable energy sector, focusing on hybrid energy storage solutions and microgrids that convert intermittent renewable energy sources into stable power supplies. Established in 2014 and headquartered in Paris, France, the company has developed advanced technologies protected by 125 patents, supported by over a decade of research and development. EPS provides a range of services, including energy storage systems for solar farms and industrial applications, as well as centralized and residential charging stations for electric vehicles. It has implemented 36 large-scale projects worldwide, totaling over 35 MW of installed power, which serves more than 165,000 customers daily. Additionally, the company has deployed over 18 MW of grid support systems, contributing to a total capacity output of 47 MWh across 21 countries, including regions in Europe, Latin America, Asia, and Africa.

Pixium Vision

Post in 2016
Pixium Vision SA is a Paris-based company focused on developing implantable medical devices to address blindness caused by the degeneration of retinal photoreceptor cells. The company is known for its bionic vision system, the PRIMA System, which aims to restore vision and enhance the quality of life for individuals suffering from vision loss. Additionally, Pixium Vision is advancing its retinal implant technologies through devices such as the IRIS1, currently in clinical trials, and the upcoming IRIS2, which promises improved visual acuity. The company is also working on the IRIS3 sub-retinal implant, leveraging cutting-edge advancements in neural processing and micro-electronics. Founded in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with leading institutions, including Stanford University and Moorfields Eye Hospital, to further its research and development efforts. The company is supported by prominent European venture capital firms.

Reduxio

Debt Financing in 2016
Since 2012 Reduxio has redefined data management and data protection, and the company has evolved its mission to deliver the first microservices-based storage and data platform for stateful applications. Reduxio’s cloud data platform for Kubernetes pairs high performance software-defined container-native storage and data management with data mobility to enable customers to build a single data cloud for their applications across all their infrastructure, anywhere. Reduxio is backed by Intel Capital, C5 Capital Cloud Partners and Jerusalem Venture Partners (JVP).

Searchmetrics

Debt Financing in 2016
Searchmetrics GmbH is a leading provider of search analytics software, primarily focused on search engine optimization (SEO) solutions for businesses worldwide. Founded in 2007 and headquartered in Berlin, the company operates the Searchmetrics Suite, a comprehensive SaaS platform that enables organizations to analyze their SEO performance, understand competitor strategies, and develop effective digital marketing campaigns. The platform offers tools for analyzing organic, paid, and universal search results, as well as social media engagement metrics. Additionally, Searchmetrics Essentials allows marketers to assess domains and keywords while predicting return on investment and identifying opportunities for competitive advantage. The company also provides consulting services through a network of partners, supporting clients in crafting long-term marketing strategies that encompass SEO, content, and social media. With a global presence, including offices in New York, San Mateo, and London, Searchmetrics serves a diverse clientele, including well-known brands such as eBay and Siemens, helping them enhance their online visibility and performance through data-driven insights.

zooz

Series C in 2016
Zooz is a technology company that provides a payments platform designed to help merchants maximize their payments performance. The company was established in 2010. In July 2018, Zooz was acquired by PayU.

Savedo

Series A in 2016
Savedo GmbH is an online marketplace based in Berlin, Germany, founded in 2014, that facilitates investment in fixed-term deposits across the European Union. The platform allows users in Germany, Austria, and the Netherlands to access better interest rates on their savings without the need to travel to different countries. By partnering with various banks, Savedo provides essential services such as customer support and standardized account documentation, streamlining the investment process for its clients. As of August 2017, Savedo operates as a subsidiary of Deposit Solutions GmbH and is staffed by a team of experienced finance professionals and online specialists dedicated to enhancing retail investment opportunities in Europe.

Marley Spoon

Series B in 2016
Marley Spoon Inc. provides a weekly meal kit service that delivers fresh ingredients and recipes directly to customers' doors. Founded in 2014 and headquartered in New York, the company allows customers to choose their meals, providing flexibility in what, when, and how they cook. By simplifying the cooking process, Marley Spoon aims to eliminate the need for grocery shopping and reduce food waste, making home cooking more accessible and enjoyable. Operating as a subsidiary of Marley Spoon AG, the company focuses on seasonal ingredients and diverse recipes to enhance the cooking experience for its users.

Widespace

Venture Round in 2016
Widespace AB operates Summit, a digital programmatic ad platform and marketplace to deliver branding campaigns on mobile. The company offers inventory marketplace, formats and ad-serving, data marketplace, and reporting solutions. It offers a range of services to media buyers and publishers in relation to their purchases and sales of advertising inventory. Widespace AB was founded in 2007 and is headquartered in Stockholm, Sweden with additional offices in Amsterdam, the Netherlands; Copenhagen, Denmark; Helsinki, Finland; London, United Kingdom; Milan, Italy; Warsaw, Poland; Oslo, Norway; Paris, France; and Stockholm, Sweden. As of July 18, 2018, Widespace AB operates as a subsidiary of Sellbranch AB.

Rewalk Robotics

Post in 2016
ReWalk Robotics Ltd. is a medical device company that specializes in the design, development, and commercialization of robotic exoskeletons aimed at individuals with mobility impairments. The company offers two primary products: the ReWalk Personal System, which supports everyday use for paraplegic individuals in various environments, including homes and workplaces, and the ReWalk Rehabilitation System, designed for therapeutic use in hospitals and rehabilitation centers. These systems enable users to walk, stand, sit, and navigate stairs, enhancing their quality of life. Additionally, ReWalk Robotics is developing ReWalk Restore, a soft suit exoskeleton intended for the rehabilitation of stroke patients. The company markets its products directly to healthcare providers and individuals, as well as through third-party distributors. Founded in 2001, ReWalk Robotics is headquartered in Yokneam Ilit, Israel, with operational facilities in Marlborough, Massachusetts.

Rockley Photonics

Venture Round in 2016
Rockley Photonics Limited, founded in 2013 and headquartered in Pasadena, California, specializes in the development of silicon photonics technologies for various applications, including data communications and consumer products. The company manufactures photonic chips and custom integrated packaged products, focusing on both chipset sales and customer-specific designs. Rockley Photonics integrates its research and development efforts to create a comprehensive range of optical modules that include supporting electronics, software, application algorithms, and AI platforms. These offerings are tailored for high-volume applications across dynamic and growing market sectors, demonstrating the company's commitment to innovation in photonics technology.

Blackwood Seven

Debt Financing in 2016
Blackwood Seven A/S is a Copenhagen-based company that offers an automated media allocation platform designed to enhance the effectiveness of advertising campaigns across various media channels, both online and offline. Founded in 2013, it specializes in video and audio media investments for dynamic businesses. The company employs predictive analytics, utilizing machine learning and artificial intelligence, to optimize media spending and improve return on investment by 15-25%. Its cloud-based platform allows for real-time modeling and comprehensive evaluation of marketing efforts, providing insights into the impact of historical spending and the effectiveness of different media channels. Blackwood Seven has additional locations in Munich, Los Angeles, New York, and Barcelona, serving a diverse clientele looking to maximize their media investments.

ChannelSight

Debt Financing in 2016
ChannelSight Ltd. is an e-commerce solutions provider based in Blackrock, Ireland, specializing in channel optimization for brands and their trade partners. Founded in 2013, the company offers a digital 'Buy Now' service, facilitating a seamless shopping experience by helping consumers locate partner retailers for their desired products. ChannelSight's technology enhances online sales through various digital marketing channels, including social media, email campaigns, and display advertising. Its offerings include tools such as Where To Buy Technology, Add To Cart Function Dynamic, and eTail Monitoring, enabling brands to track customer journeys and refine their online strategies. The company serves multiple sectors, including video games, FMCG, fashion, and consumer electronics, and operates on a global scale.

LiquidM

Debt Financing in 2016
LiquidM Technology GmbH, founded in 2013 and based in Berlin, Germany, offers a comprehensive advertising and campaign management platform designed for mobile media buyers, ad networks, and mobile operators. As a subsidiary of Smart AdServer SAS, LiquidM provides a white-labeled, cloud-based solution that allows users to set up and manage advertisements with customizable settings, targets, and supply partners. The platform supports integration with third-party solutions, including data management and attribution tools, facilitating efficient campaign execution. With a focus on modular design, LiquidM empowers agencies and advertisers to optimize their ad tech infrastructure, enhancing control and delivering deeper insights into media planning and purchasing. The company's technology combines media, data, and strategy to drive better results in the mobile display media marketplace, supporting real-time bidding and audience targeting based on various criteria.

CropX

Debt Financing in 2016
CropX Ltd., an ag-analytics company, develops cloud based software solutions integrated with wireless sensors, which boosts crops yield and saves water and energy. It offers advanced adaptive irrigation software service that delivers crop yield increase, and water and energy cost saving services while conserving the environment. The company also generates irrigation maps and automatically applies the right amount of water to different parts of the same field. It serves farmers worldwide. CropX Ltd. was founded in 2013 and is headquartered in Tel Aviv, Israel with an additional office in San Francisco, California. CropX’s proprietary science helps farmers better understand water usage across their fields. Its low-cost soil sensors can increase crop yields while simultaneously cutting water usage by one third. In just one irrigation season, CropX sensors were installed on thousands of acres of all major row crops and demonstrated immense value, with early customers across the United States reporting dramatic water, manpower and cost savings, as well as massive crop yield gains. During the current growing season, CropX technology will be rolled out across hundreds of thousands of acres.

Sckipio

Venture Round in 2015
Sckipio Corporation is a semiconductor company specializing in G.fast-based modems that facilitate ultra high-speed broadband access. Founded in 2012 and headquartered in Ramat Gan, Israel, Sckipio focuses on technologies that enable telecommunications providers to deliver speeds of up to 1 Gbps per subscriber, supporting applications such as fiber-to-the-distribution-point, multi-dwelling units, and mobile backhaul. The company is notable for being the first to offer G.fast modems and has made significant contributions to the G.fast standard, accounting for over 20% of its development. Sckipio's innovative solutions enable faster broadband access over existing infrastructures, aiming to make high-speed internet more widely available.

Thread

Series A in 2015
Thread Online Limited is an online retail platform based in London, United Kingdom, that specializes in clothing, shoes, and accessories for men and women. Founded in 2012, the company combines the expertise of human stylists with machine learning algorithms to provide personalized fashion recommendations. Customers receive tailored suggestions that reflect their preferences, style, size, and budget, allowing them to discover suitable clothing without the need for traditional shopping. This unique approach enhances the online shopping experience by blending professional guidance with advanced technology, making it easier for individuals to dress well.

Novacyt

Post in 2015
Novacyt is an international diagnostics company focused on developing and selling in vitro and molecular diagnostic tests for cancer and infectious diseases. The business operates through several segments, including Primerdesign, IT-IS International, and Lab21 Products, which provide a diverse range of high-quality assays and reagents to the global market. Novacyt's primary strengths include diagnostics product development, commercialization, and contract design and manufacturing. The company serves key markets such as oncology, microbiology, hematology, and serology, catering to both direct customers and global partners, including major corporations. The Yourgene Health segment generates the majority of the company's revenue, contributing to its rapid growth within the diagnostics industry.

Artesian Solutions

Series B in 2015
Artesian Solutions Limited specializes in developing web-based market intelligence and sales surveillance software tailored for businesses. The company gathers and analyzes data from a wide range of online sources, transforming this information into actionable insights relevant to users' specific industries and companies. Its sales solutions incorporate real-time analysis of news, blogs, and social media alongside verified corporate data, enabling users to identify quality leads and engage effectively with prospects. Artesian's platform aims to enhance B2B relationships by providing tools that facilitate meaningful customer interactions and support revenue growth. Additionally, for organizations in regulated sectors, Artesian offers the Risk and Compliance Hub (ARCH), which monitors credit risk and KYC data in real-time, ensuring compliance with internal policies. Founded in 2006, Artesian is headquartered in Winnersh, United Kingdom, with an office in Boston, Massachusetts.

Crocus Technology

Series E in 2015
Crocus Technology International Corp. specializes in developing and supplying magnetic sensors and embedded memory solutions based on its patented magnetic logic unit technology. The company provides a range of magnetic sensor products, which include various architectures suitable for challenging environments, such as oil drilling, fluid level measurements, and solar energy applications. Its offerings cater to diverse sectors, including industrial, automotive, consumer electronics, and the Internet of Things. Additionally, Crocus Technology delivers magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries, addressing needs in telecommunications, networking, storage, computing, and handheld devices. Established in 2014, the company is headquartered in Santa Clara, California, with an additional office in Grenoble, France, and distributes its products through a network of sales distributors both domestically and internationally.

Auctionata

Series C in 2015
Auctionata was an online auction platform that specialized in art, antiques, and luxury collectibles. The company operated a live-stream auction portal, allowing bidders globally to participate in real-time auctions. Auctionata had a presence in multiple cities, including Berlin, New York, London, and Los Angeles, among others. However, as of February 29, 2017, Auctionata announced the cessation of its operations and declared insolvency. Following this announcement, its German operations were halted, although the subsidiaries Paddle8 in the United States and Value-my-Stuff in the United Kingdom were sold and continue to function independently.

Spotcap

Debt Financing in 2015
Spotcap empowers SMEs with tailored finance, allowing them to focus on their business. The company operates as a direct lender to SMEs in the United Kingdom, the Netherlands, Spain, Australia and New Zealand where they offer promising businesses access to flexible finance. Spotcap’s online application is straightforward and can be completed in as little as five minutes, either online or in collaboration with a financial advisor, broker or accountant. Spotcap was founded in 2014 and is headquartered in Berlin.

Riskified

Debt Financing in 2015
Riskified Ltd. operates a fraud prevention platform tailored for online merchants, integrating seamlessly with various e-commerce systems to deliver actionable decisions on transaction legitimacy. Founded in 2013 and based in Tel Aviv, Israel, Riskified utilizes machine learning algorithms and proprietary behavioral analytics to help retailers manage fraud effectively while enhancing customer experience. The platform adapts to the evolving fraud landscape, enabling merchants to reduce overhead costs and maximize revenue. Riskified generates revenue by providing access to its risk management services, which include reviewing and approving transactions for a diverse range of clients, including well-known brands such as Wayfair, SHEIN, and Macy's. Its client base spans multiple sectors, including fashion, electronics, and travel, with the majority of revenue originating from Israel.

myTomorrows

Debt Financing in 2015
myTomorrows is a healthcare information platform that facilitates access to innovative drugs in development for patients and physicians who are often excluded from clinical trials. The company focuses on areas with significant unmet medical needs, including oncology, neurology, psychiatry, and rare diseases. By identifying promising treatments and gathering relevant information, myTomorrows informs both patients and healthcare providers about available drug options. The platform enables users to request access to these innovative therapies, thereby improving the chances for patients to receive potentially life-saving treatments that are otherwise difficult to obtain.

ToucanBox

Venture Round in 2015
ToucanBox is a subscription-based service that provides educational and entertaining activity boxes for children aged 3 to 8. Each box contains all the materials needed to complete one to four projects, along with easy-to-follow instructions and a reading book to stimulate learning. Designed by educational experts, the activities aim to engage children and develop essential skills while encouraging creativity. The company delivers a new themed box monthly or bi-weekly, offering a variety of stimulating projects that inspire curiosity and exploration in young learners. Through its innovative approach, ToucanBox fosters both educational growth and enjoyment in children's learning experiences.

Adbrain

Debt Financing in 2015
Adbrain Ltd. operates a self-service, multi-screen demand-side advertising platform that specializes in customer identity resolution for marketers. Founded in 2012 and based in London, with additional operations in New York, the company provides technology that maps customer relationships across various internet-connected devices and channels. This platform enables marketers to create an actionable single customer view and effectively target users as they switch between devices. Adbrain's intelligence technology facilitates the development of advanced customer ID maps, allowing advertisers to better understand and engage their audience, both online and offline. The platform also promotes a transparent media buying model, empowering advertisers to run campaigns and gain insights independently. As of October 2017, Adbrain operates as a subsidiary of The Trade Desk, Inc.

Dreamlines

Debt Financing in 2015
Dreamlines GmbH, founded in 2012 and headquartered in Hamburg, Germany, is an online travel agency specializing in cruise-related travel. The company provides a diverse array of cruise options, including family, river, luxury, and mini cruises, as well as packages for singles and round trips that can include flights. Dreamlines has established itself as the largest cruise portal in Europe and is rapidly expanding its global presence, operating in 12 countries across five continents. With over 600 dedicated employees, it focuses on enhancing customer satisfaction through a proprietary GDS/CRM system tailored to the unique needs of the cruise industry. The company also offers exclusive cruise packages designed by experienced cruise experts, further solidifying its position as a leading player in the online cruise booking market.

Poxel

Series B in 2014
Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.

Bluevine

Series A in 2014
BlueVine Capital Inc. is a financial technology company based in Redwood City, California, that specializes in providing working capital solutions to small businesses in the United States. Founded in 2013, BlueVine offers a variety of financial products including lines of credit, term loans, and invoice factoring, aimed at addressing the diverse financial needs of small and medium-sized enterprises. The company has developed an advanced online platform that enables business owners to access financing quickly and easily, featuring fast approvals and a user-friendly dashboard. Since its inception, BlueVine has facilitated nearly $2 billion in financing, helping businesses manage their cash flow challenges effectively. In addition to its financial products, BlueVine also offers a Business Checking Account to further support small business owners.

Inneractive

Series C in 2014
Inneractive Ltd. is a mobile ad exchange company based in Petach Tikva, Israel, with additional offices in San Francisco, New York, and London. Founded in 2007, the company specializes in enabling the buying and selling of display, native, and video advertisements. Inneractive provides a range of solutions tailored for publishers, developers, and demand partners, which include audience buying solutions and automated processes through its technology platform. The company aims to empower mobile publishers to maximize their properties’ potential by offering innovative tools and insights. As of mid-2016, Inneractive operates as a subsidiary of RNTS Media N.V.

Monedo

Debt Financing in 2014
Monedo Holding GmbH specializes in providing credit lending solutions through advanced technology, particularly focusing on the underbanked population. The company employs machine-learning algorithms and big data scoring to enhance credit decision-making and accessibility. Its product lineup includes customized installment loans, microloans through Kredito24, a digital wallet, and a personal finance manager aimed at helping customers manage their finances effectively. Additionally, Monedo offers a "Lending as a Service" model, enabling partners to integrate its credit products via API into their platforms. Founded in 2012 and headquartered in Hamburg, Germany, Monedo operates across multiple markets, including Poland, Romania, Russia, Spain, and Thailand, processing over four million loan applications to date. The company is led by CEO and Co-Founder Alexander Graubner-Müller and is supported by prominent investors.

Delivery Hero

Series E in 2014
Delivery Hero is a global network of online food ordering platforms, operating in 21 countries and partnering with over 73,000 restaurants. The company has a significant presence in various markets, including Germany, the UK, South Korea, and Brazil, among others. With a workforce exceeding 1,000 employees, around 400 are based at its headquarters in Berlin. Delivery Hero has attracted substantial investment, notably receiving $523 million in 2014 from various prominent investors. The company focuses on connecting consumers with local restaurants, facilitating the ordering and delivery process through its digital platforms.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.